ConductScience.org, home

Trial · NCT02912988

Letrozole in Stimulated IVF Cycles

NCT02912988, Phase 3, Completed, The University of Hong Kong

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Letrozole in Stimulated IVF Cycles. Trials, record NCT02912988. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02912988

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Letrozole in Stimulated IVF Cycles
NCT number
NCT02912988
Status
Completed
Phases
Phase 3
Enrollment
900 participants, actual
Lead sponsor
The University of Hong Kong
Conditions
Subfertility
Interventions
Letrozole
First posted
2016-09-23
Last updated
2023-05-10

Source ClinicalTrials.gov

Registered outcomes20

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryLive birth ratethrough study completion, an average of 1 yearA baby born alive after 20 weeks gestation
SecondaryMiscarriage rateup to 20 weeks of gestationMiscarriage before 20 weeks gestation
SecondaryClinical and ongoing pregnancy ratesup to 20 weeksPresence of at least one gestational sac on ultrasound at 6 weeks and 8-10 weeks
SecondaryOvarian hyperstimulation rateabout 1 monthOvarian hyperstimulation rate classified according to Royal College of Obstetrics and Gynaecology of the United Kingdom
SecondaryTotal IU of FSH used per cycleabout 2 weeksTotal IU of FSH used per cycle
SecondaryNumber of follicles > 12 mm on day of hCG (or the day before)about 2 weeksTransvaginal ultrasound performed to measure and the follicles on day of hcG or the day before.
SecondaryNumber of oocytes obtainedOn the operation day of transvaginal ultrasound guided oocyte retrievalNumber of oocyte obtained during the operation of transvaginal ultrasound guided oocyte retrieval
SecondaryProportion of oocytes resulting in top quality day 2 (or day 3) embryos according to validated morphological criteria.2-3 days after the transvaginal ultrasound guided oocyte retrieval operationProportion of oocytes resulting in top quality day 2 (or day 3) embryos according to validated morphological criteria.
SecondaryOocyte fertilization rate2-3 days after the transvaginal ultrasound guided oocyte retrieval operationOocyte fertilization rate
SecondaryNumber and quality of embryos obtained2-3 days after the transvaginal ultrasound guided oocyte retrieval operationNumber and quality of embryos obtained

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers1

The papers the trial lists on ClinicalTrials.gov.

PMIDListed as
35365197DERIVED

Source PubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT02912988

GET https://conductscience.org/api/trials/v1/NCT02912988/registered